Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT).

Shore ND, Saltzstein D, Sieber P, Mehlhaff B, Gervasi L, Phillips J, Wong YN, Pei H, McGowan T.

Clin Genitourin Cancer. 2019 Aug 6. pii: S1558-7673(19)30245-9. doi: 10.1016/j.clgc.2019.07.017. [Epub ahead of print]

PMID:
31473120
2.

Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.

Sieber P, Schäfer A, Lieberherr R, Le Goff F, Stritt M, Welford RWD, Gatfield J, Peter O, Nayler O, Lüthi U.

PLoS One. 2018 Nov 28;13(11):e0207872. doi: 10.1371/journal.pone.0207872. eCollection 2018.

3.

Comparative Study on Alternative Splicing in Human Fungal Pathogens Suggests Its Involvement During Host Invasion.

Sieber P, Voigt K, Kämmer P, Brunke S, Schuster S, Linde J.

Front Microbiol. 2018 Oct 2;9:2313. doi: 10.3389/fmicb.2018.02313. eCollection 2018.

4.

Denervation leads to volume regression in breast cancer.

Kappos EA, Engels PE, Tremp M, Sieber PK, von Felten S, Madduri S, Meyer Zu Schwabedissen M, Fischmann A, Schaefer DJ, Kalbermatten DF.

J Plast Reconstr Aesthet Surg. 2018 Jun;71(6):833-839. doi: 10.1016/j.bjps.2018.03.012. Epub 2018 Mar 28.

PMID:
29653898
5.

From Bedside to Bench: The Effect of Muscular Denervation on Fat Grafting to the Breast by Comparing Take Rate, Quality, and Longevity.

Engels PE, Kappos EA, Sieber PK, Benz RM, Thommen S, Schaefer DJ, Kalbermatten DF.

Aesthet Surg J. 2018 Jul 13;38(8):900-910. doi: 10.1093/asj/sjy073.

PMID:
29596609
6.

The Definition of Open Reading Frame Revisited.

Sieber P, Platzer M, Schuster S.

Trends Genet. 2018 Mar;34(3):167-170. doi: 10.1016/j.tig.2017.12.009. Epub 2018 Jan 30.

PMID:
29366605
7.

Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models.

Kappos EA, Sieber PK, Engels PE, Mariolo AV, D'Arpa S, Schaefer DJ, Kalbermatten DF.

Brain Behav. 2017 May 18;7(7):e00723. doi: 10.1002/brb3.723. eCollection 2017 Jul.

8.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW.

Cancer. 2017 Aug 1;123(15):2850-2859. doi: 10.1002/cncr.30665. Epub 2017 Apr 19.

9.

The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II).

Crawford ED, Petrylak DP, Shore N, Saad F, Slovin SF, Vogelzang NJ, Keane TE, Koo PJ, Gomella LG, O'Sullivan JM, Tombal B, Concepcion RS, Sieber P, Stone NN, Finkelstein SE, Yu EY; Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR II) Group.

Urology. 2017 Jun;104:150-159. doi: 10.1016/j.urology.2016.12.033. Epub 2017 Mar 14. Review.

PMID:
28302580
10.

Prevalence of pasture-associated metazoal endoparasites in Bavarian dairy goat herds and farmers' approaches to parasite control.

Voigt K, Sieber PL, Sauter-Louis C, Knubben-Schweizer G, Scheuerle M.

Berl Munch Tierarztl Wochenschr. 2016 Jul-Aug;129(7-8):323-32.

PMID:
27529995
11.

Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation.

Welford RW, Vercauteren M, Trébaul A, Cattaneo C, Eckert D, Garzotti M, Sieber P, Segrestaa J, Studer R, Groenen PM, Nayler O.

Sci Rep. 2016 Jul 21;6:30059. doi: 10.1038/srep30059.

12.

Berne: du cannabis bientôt disponible en pharmacie.

Sieber PA.

Rev Med Suisse. 2016 Mar 23;12(511):623. French. No abstract available.

PMID:
27188063
13.

Novel S1P1 receptor agonists - Part 4: Alkylaminomethyl substituted aryl head groups.

Lescop C, Müller C, Mathys B, Birker M, de Kanter R, Kohl C, Hess P, Nayler O, Rey M, Sieber P, Steiner B, Weller T, Bolli MH.

Eur J Med Chem. 2016 Jun 30;116:222-238. doi: 10.1016/j.ejmech.2016.03.048. Epub 2016 Mar 23.

PMID:
27061986
14.

Novel S1P1 receptor agonists - Part 5: From amino-to alkoxy-pyridines.

Bolli MH, Lescop C, Birker M, de Kanter R, Hess P, Kohl C, Nayler O, Rey M, Sieber P, Velker J, Weller T, Steiner B.

Eur J Med Chem. 2016 Jun 10;115:326-41. doi: 10.1016/j.ejmech.2016.03.020. Epub 2016 Mar 12.

PMID:
27027817
15.

Seroprevalence of Schmallenberg virus infection in sheep and goats flocks in Germany, 2012-2013.

Helmer C, Eibach R, Humann-Ziehank E, Tegtmeyer PC, Bürstel D, Mayer K, Moog U, Stauch S, Strobel H, Voigt K, Sieber P, Greiner M, Ganter M.

Vet Med Sci. 2016 Jan 11;2(1):10-22. doi: 10.1002/vms3.14. eCollection 2016 Feb.

16.

A Genetic Screen for Mutations Affecting Cell Division in the Arabidopsis thaliana Embryo Identifies Seven Loci Required for Cytokinesis.

Gillmor CS, Roeder AH, Sieber P, Somerville C, Lukowitz W.

PLoS One. 2016 Jan 8;11(1):e0146492. doi: 10.1371/journal.pone.0146492. eCollection 2016.

17.

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I, Fujiwara Y, Martín M, Paterson A, Tonkin K, Shore N, Sieber P, Kueppers F, Karsh L, Yardley D, Wang H, Maniar T, Arellano J, Braun A.

Support Care Cancer. 2016 Jan;24(1):457-458. doi: 10.1007/s00520-015-2985-1. No abstract available.

18.

A Hybrid Approach for Efficient Modeling of Medium-Frequency Propagation in Coal Mines.

Brocker DE, Sieber PE, Waynert JA, Li J, Werner PL, Werner DH.

IEEE Antennas Propag Mag. 2015 Feb;174(1):164-176. Epub 2015 Mar 9.

19.

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.

Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I, Fujiwara Y, Martín M, Paterson A, Tonkin K, Shore N, Sieber P, Kueppers F, Karsh L, Yardley D, Wang H, Maniar T, Arellano J, Braun A.

Support Care Cancer. 2016 Jan;24(1):447-455. doi: 10.1007/s00520-015-2904-5. Epub 2015 Sep 3. Erratum in: Support Care Cancer. 2015 Oct 19;:.

20.

[The Swiss champion prosthesis implantation].

Sieber PA.

Rev Med Suisse. 2015 Jan 21;11(458):226. French. No abstract available.

PMID:
25831623
21.

Infrared broadband quarter-wave and half-wave plates synthesized from anisotropic Bézier metasurfaces.

Sieber PE, Werner DH.

Opt Express. 2014 Dec 29;22(26):32371-83. doi: 10.1364/OE.22.032371.

PMID:
25607201
22.

Defining the transcriptomic landscape of Candida glabrata by RNA-Seq.

Linde J, Duggan S, Weber M, Horn F, Sieber P, Hellwig D, Riege K, Marz M, Martin R, Guthke R, Kurzai O.

Nucleic Acids Res. 2015 Feb 18;43(3):1392-406. doi: 10.1093/nar/gku1357. Epub 2015 Jan 13.

23.

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I, Gambla M, Grable MS, Henderson RJ, Karsh L, Krisch EB, Langford TD, Lin DW, McGee SM, Munoz JJ, Pieczonka CM, Rieger-Christ K, Saltzstein DR, Scott JW, Shore ND, Sieber PR, Waldmann TM, Wolk FN, Zappala SM.

Eur Urol. 2015 Sep;68(3):464-70. doi: 10.1016/j.eururo.2014.10.021. Epub 2014 Oct 27.

PMID:
25454615
24.

Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer.

Padhi D, Higano CS, Shore ND, Sieber P, Rasmussen E, Smith MR.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1967-75. doi: 10.1210/jc.2014-1271. Epub 2014 Jun 27.

PMID:
24971661
26.

Challenges and recommendations for early identification of metastatic disease in prostate cancer.

Crawford ED, Stone NN, Yu EY, Koo PJ, Freedland SJ, Slovin SF, Gomella LG, Berger ER, Keane TE, Sieber P, Shore ND, Petrylak DP; Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence (RADAR) Group.

Urology. 2014 Mar;83(3):664-9. doi: 10.1016/j.urology.2013.10.026. Epub 2014 Jan 8. Review.

PMID:
24411213
27.

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer.

Shore ND, Sieber P, Schimke L, Perzin A, Olsen S.

Urol Nurs. 2013 Sep-Oct;33(5):236-44, 248.

PMID:
24354113
28.

Five-year results of laparoscopic sleeve gastrectomy.

Sieber P, Gass M, Kern B, Peters T, Slawik M, Peterli R.

Surg Obes Relat Dis. 2014 Mar-Apr;10(2):243-9. doi: 10.1016/j.soard.2013.06.024. Epub 2013 Jul 10.

PMID:
24139922
29.

Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.

Smith MR, Saad F, Oudard S, Shore N, Fizazi K, Sieber P, Tombal B, Damiao R, Marx G, Miller K, Van Veldhuizen P, Morote J, Ye Z, Dansey R, Goessl C.

J Clin Oncol. 2013 Oct 20;31(30):3800-6. doi: 10.1200/JCO.2012.44.6716. Epub 2013 Sep 16.

30.

Reconfigurable broadband infrared circularly polarizing reflectors based on phase changing birefringent metasurfaces.

Sieber PE, Werner DH.

Opt Express. 2013 Jan 14;21(1):1087-100. doi: 10.1364/OE.21.001087.

PMID:
23389002
31.

Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.

Taneja SS, Morton R, Barnette G, Sieber P, Hancock ML, Steiner M.

J Clin Oncol. 2013 Feb 10;31(5):523-9. doi: 10.1200/JCO.2012.41.7634. Epub 2013 Jan 7.

PMID:
23295793
32.

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D, Hancock ML, Steiner MS.

J Urol. 2013 Jan;189(1 Suppl):S45-50. doi: 10.1016/j.juro.2012.11.016.

PMID:
23234631
33.

Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.

Sieber P, Lardelli P, Kraenzlin CA, Kraenzlin ME, Meier C.

Clin Drug Investig. 2013 Feb;33(2):117-22. doi: 10.1007/s40261-012-0041-1.

PMID:
23184667
34.

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer.

Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH, Stockton BR, Hertzman BL, Efros MD, Roper RP, Liker HR, Carducci MA.

Prostate Cancer Prostatic Dis. 2013 Mar;16(1):50-5. doi: 10.1038/pcan.2012.20. Epub 2012 Jun 12.

35.

Sarcopenia during androgen-deprivation therapy for prostate cancer.

Smith MR, Saad F, Egerdie B, Sieber PR, Tammela TL, Ke C, Leder BZ, Goessl C.

J Clin Oncol. 2012 Sep 10;30(26):3271-6. doi: 10.1200/JCO.2011.38.8850. Epub 2012 May 29.

36.

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.

Egerdie RB, Saad F, Smith MR, Tammela TL, Heracek J, Sieber P, Ke C, Leder B, Dansey R, Goessl C.

Prostate Cancer Prostatic Dis. 2012 Sep;15(3):308-12.

37.

The role of distal third radius dual energy X-ray absorptiometry (DXA) and central DXA in evaluating for osteopenia and osteoporosis in men receiving androgen deprivation therapy for prostate cancer.

Sieber PR, Rommel FM, Theodoran CG, Russinko PJ, Woodward CA, Schimke L.

J Clin Densitom. 2012 Jul-Sep;15(3):351-4. doi: 10.1016/j.jocd.2012.01.010. Epub 2012 Apr 26.

PMID:
22542224
38.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C.

Lancet. 2012 Jan 7;379(9810):39-46. doi: 10.1016/S0140-6736(11)61226-9. Epub 2011 Nov 15.

39.

Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer.

Smith MR, Saad F, Egerdie B, Sieber P, Tammela TLj, Leder BZ, Ke C, Goessl C.

J Bone Miner Res. 2011 Dec;26(12):2827-33. doi: 10.1002/jbmr.492.

40.

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D, Hancock ML, Steiner MS.

J Urol. 2010 Oct;184(4):1316-21. doi: 10.1016/j.juro.2010.06.022. Epub 2010 Aug 17. Erratum in: J Urol. 2011 Jan;185(1):365.

41.

Toremifene improves lipid profiles in men receiving androgen-deprivation therapy for prostate cancer: interim analysis of a multicenter phase III study.

Smith MR, Malkowicz SB, Chu F, Forrest J, Sieber P, Barnette KG, Rodriquez D, Steiner MS.

J Clin Oncol. 2008 Apr 10;26(11):1824-9. doi: 10.1200/JCO.2007.13.5517.

42.

Treatment of bicalutamide-induced breast events.

Sieber PR.

Expert Rev Anticancer Ther. 2007 Dec;7(12):1773-9. Review.

PMID:
18062751
43.

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.

Smith MR, Malkowicz SB, Chu F, Forrest J, Price D, Sieber P, Barnette KG, Rodriguez D, Steiner MS.

J Urol. 2008 Jan;179(1):152-5. Epub 2007 Nov 14.

44.

Contemporary prostate biopsy complication rates in community-based urology practice.

Sieber PR, Rommel FM, Theodoran CG, Hong RD, Del Terzo MA.

Urology. 2007 Sep;70(3):498-500.

PMID:
17905105
45.

Histoplasma phimosis: an uncommon presentation of a not uncommon pathogen.

Ariyanayagam-Baksh SM, Baksh FK, Cartun RW, Sieber PR.

Am J Dermatopathol. 2007 Jun;29(3):300-2.

PMID:
17519632
46.

Redundancy and specialization among plant microRNAs: role of the MIR164 family in developmental robustness.

Sieber P, Wellmer F, Gheyselinck J, Riechmann JL, Meyerowitz EM.

Development. 2007 Mar;134(6):1051-60. Epub 2007 Feb 7.

47.

Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M.

J Urol. 2006 Sep;176(3):965-70; discussion 970-1.

PMID:
16890670
48.

Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.

Wagg A, Wyndaele JJ, Sieber P.

Am J Geriatr Pharmacother. 2006 Mar;4(1):14-24.

PMID:
16730617
49.

Patterns of auxin transport and gene expression during primordium development revealed by live imaging of the Arabidopsis inflorescence meristem.

Heisler MG, Ohno C, Das P, Sieber P, Reddy GV, Long JA, Meyerowitz EM.

Curr Biol. 2005 Nov 8;15(21):1899-911.

50.

The early extra petals1 mutant uncovers a role for microRNA miR164c in regulating petal number in Arabidopsis.

Baker CC, Sieber P, Wellmer F, Meyerowitz EM.

Curr Biol. 2005 Feb 22;15(4):303-15.

Supplemental Content

Loading ...
Support Center